SUSS MICROTEC SE (SMHN.DE) Fundamental Analysis & Valuation

FRA:SMHNDE000A1K0235

Current stock price

59.9 EUR
+1.95 (+3.36%)
Last:

This SMHN.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. SMHN.DE Profitability Analysis

1.1 Basic Checks

  • In the past year SMHN was profitable.
  • SMHN had a negative operating cash flow in the past year.
  • SMHN had positive earnings in each of the past 5 years.
  • SMHN had a positive operating cash flow in 4 of the past 5 years.
SMHN.DE Yearly Net Income VS EBIT VS OCF VS FCFSMHN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

  • SMHN has a Return On Assets of 9.09%. This is comparable to the rest of the industry: SMHN outperforms 56.34% of its industry peers.
  • SMHN's Return On Equity of 14.61% is in line compared to the rest of the industry. SMHN outperforms 49.30% of its industry peers.
  • With a decent Return On Invested Capital value of 12.01%, SMHN is doing good in the industry, outperforming 60.56% of the companies in the same industry.
  • SMHN had an Average Return On Invested Capital over the past 3 years of 14.00%. This is in line with the industry average of 14.74%.
Industry RankSector Rank
ROA 9.09%
ROE 14.61%
ROIC 12.01%
ROA(3y)10.79%
ROA(5y)9.01%
ROE(3y)18.71%
ROE(5y)16.03%
ROIC(3y)14%
ROIC(5y)12.84%
SMHN.DE Yearly ROA, ROE, ROICSMHN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

1.3 Margins

  • SMHN's Profit Margin of 9.16% is on the low side compared to the rest of the industry. SMHN is outperformed by 61.97% of its industry peers.
  • In the last couple of years the Profit Margin of SMHN has grown nicely.
  • SMHN has a Operating Margin of 13.09%. This is comparable to the rest of the industry: SMHN outperforms 46.48% of its industry peers.
  • In the last couple of years the Operating Margin of SMHN has grown nicely.
  • The Gross Margin of SMHN (35.65%) is worse than 78.87% of its industry peers.
  • In the last couple of years the Gross Margin of SMHN has remained more or less at the same level.
Industry RankSector Rank
OM 13.09%
PM (TTM) 9.16%
GM 35.65%
OM growth 3Y-3.44%
OM growth 5Y4.44%
PM growth 3Y-0.96%
PM growth 5Y13.32%
GM growth 3Y-3.92%
GM growth 5Y0.37%
SMHN.DE Yearly Profit, Operating, Gross MarginsSMHN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

5

2. SMHN.DE Health Analysis

2.1 Basic Checks

  • SMHN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, SMHN has about the same amount of shares outstanding.
  • SMHN has about the same amout of shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, SMHN has a worse debt to assets ratio.
SMHN.DE Yearly Shares OutstandingSMHN.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
SMHN.DE Yearly Total Debt VS Total AssetsSMHN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • An Altman-Z score of 6.21 indicates that SMHN is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 6.21, SMHN is in line with its industry, outperforming 57.75% of the companies in the same industry.
  • A Debt/Equity ratio of 0.14 indicates that SMHN is not too dependend on debt financing.
  • SMHN has a better Debt to Equity ratio (0.14) than 61.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z 6.21
ROIC/WACC1.07
WACC11.22%
SMHN.DE Yearly LT Debt VS Equity VS FCFSMHN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 3.28 indicates that SMHN has no problem at all paying its short term obligations.
  • The Current ratio of SMHN (3.28) is better than 76.06% of its industry peers.
  • SMHN has a Quick Ratio of 1.83. This is a normal value and indicates that SMHN is financially healthy and should not expect problems in meeting its short term obligations.
  • SMHN has a Quick ratio of 1.83. This is comparable to the rest of the industry: SMHN outperforms 49.30% of its industry peers.
Industry RankSector Rank
Current Ratio 3.28
Quick Ratio 1.83
SMHN.DE Yearly Current Assets VS Current LiabilitesSMHN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

6

3. SMHN.DE Growth Analysis

3.1 Past

  • SMHN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.78%.
  • SMHN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 32.42% yearly.
  • SMHN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.78%.
  • SMHN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.82% yearly.
EPS 1Y (TTM)-4.78%
EPS 3Y23.48%
EPS 5Y32.42%
EPS Q2Q%-41.38%
Revenue 1Y (TTM)12.78%
Revenue growth 3Y24.62%
Revenue growth 5Y14.82%
Sales Q2Q%-21.28%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.08% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 8.29% on average over the next years. This is quite good.
EPS Next Y-24.44%
EPS Next 2Y5.3%
EPS Next 3Y14.19%
EPS Next 5Y15.08%
Revenue Next Year-6.72%
Revenue Next 2Y2.78%
Revenue Next 3Y7.18%
Revenue Next 5Y8.29%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SMHN.DE Yearly Revenue VS EstimatesSMHN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
SMHN.DE Yearly EPS VS EstimatesSMHN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

2

4. SMHN.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 23.13, which indicates a rather expensive current valuation of SMHN.
  • Compared to the rest of the industry, the Price/Earnings ratio of SMHN indicates a somewhat cheap valuation: SMHN is cheaper than 78.87% of the companies listed in the same industry.
  • SMHN's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.34.
  • SMHN is valuated quite expensively with a Price/Forward Earnings ratio of 30.61.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of SMHN is on the same level as its industry peers.
  • SMHN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 38.18, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 23.13
Fwd PE 30.61
SMHN.DE Price Earnings VS Forward Price EarningsSMHN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 71.83% of the companies in the same industry are more expensive than SMHN, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.61
SMHN.DE Per share dataSMHN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

  • SMHN's earnings are expected to grow with 14.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)0.71
EPS Next 2Y5.3%
EPS Next 3Y14.19%

2

5. SMHN.DE Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.07%, SMHN is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.65, SMHN has a dividend in line with its industry peers.
  • With a Dividend Yield of 0.07, SMHN pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.07%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years3
SMHN.DE Yearly Dividends per shareSMHN.DE Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 2026 0 0 0 0 0

5.3 Sustainability

  • SMHN pays out 12.44% of its income as dividend. This is a sustainable payout ratio.
DP12.44%
EPS Next 2Y5.3%
EPS Next 3Y14.19%
SMHN.DE Yearly Income VS Free CF VS DividendSMHN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M
SMHN.DE Dividend Payout.SMHN.DE Dividend Payout, showing the Payout Ratio.SMHN.DE Dividend Payout.PayoutRetained Earnings

SMHN.DE Fundamentals: All Metrics, Ratios and Statistics

SUSS MICROTEC SE

FRA:SMHN (4/14/2026, 7:00:00 PM)

59.9

+1.95 (+3.36%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)03-27
Earnings (Next)05-07
Inst Owners70.95%
Inst Owner ChangeN/A
Ins Owners0.15%
Ins Owner ChangeN/A
Market Cap1.15B
Revenue(TTM)503.18M
Net Income(TTM)46.10M
Analysts83.53
Price Target57.58 (-3.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.07%
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DP12.44%
Div Incr Years1
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)29.81%
Min EPS beat(2)-12.2%
Max EPS beat(2)71.82%
EPS beat(4)3
Avg EPS beat(4)23.49%
Min EPS beat(4)-12.2%
Max EPS beat(4)71.82%
EPS beat(8)6
Avg EPS beat(8)22.77%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)7.36%
Min Revenue beat(2)5.15%
Max Revenue beat(2)9.56%
Revenue beat(4)4
Avg Revenue beat(4)11.63%
Min Revenue beat(4)5.15%
Max Revenue beat(4)18.24%
Revenue beat(8)6
Avg Revenue beat(8)8.33%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.38%
PT rev (3m)23.33%
EPS NQ rev (1m)-8.79%
EPS NQ rev (3m)-30.36%
EPS NY rev (1m)-3.18%
EPS NY rev (3m)-0.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)15.08%
Revenue NY rev (1m)4.4%
Revenue NY rev (3m)8.06%
Valuation
Industry RankSector Rank
PE 23.13
Fwd PE 30.61
P/S 2.28
P/FCF N/A
P/OCF N/A
P/B 3.63
P/tB 3.9
EV/EBITDA 13.61
EPS(TTM)2.59
EY4.32%
EPS(NY)1.96
Fwd EY3.27%
FCF(TTM)-1.18
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS26.32
BVpS16.5
TBVpS15.36
PEG (NY)N/A
PEG (5Y)0.71
Graham Number31.01
Profitability
Industry RankSector Rank
ROA 9.09%
ROE 14.61%
ROCE 16.91%
ROIC 12.01%
ROICexc 16.14%
ROICexgc 17.46%
OM 13.09%
PM (TTM) 9.16%
GM 35.65%
FCFM N/A
ROA(3y)10.79%
ROA(5y)9.01%
ROE(3y)18.71%
ROE(5y)16.03%
ROIC(3y)14%
ROIC(5y)12.84%
ROICexc(3y)21.24%
ROICexc(5y)19.01%
ROICexgc(3y)24.2%
ROICexgc(5y)22.08%
ROCE(3y)19.7%
ROCE(5y)18.07%
ROICexgc growth 3Y-6.91%
ROICexgc growth 5Y-0.71%
ROICexc growth 3Y-3.71%
ROICexc growth 5Y1.78%
OM growth 3Y-3.44%
OM growth 5Y4.44%
PM growth 3Y-0.96%
PM growth 5Y13.32%
GM growth 3Y-3.92%
GM growth 5Y0.37%
F-Score3
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA 0.58
Cap/Depr 182.74%
Cap/Sales 4.29%
Interest Coverage 53.95
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.28
Quick Ratio 1.83
Altman-Z 6.21
F-Score3
WACC11.22%
ROIC/WACC1.07
Cap/Depr(3y)115.5%
Cap/Depr(5y)113.96%
Cap/Sales(3y)2.5%
Cap/Sales(5y)2.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.78%
EPS 3Y23.48%
EPS 5Y32.42%
EPS Q2Q%-41.38%
EPS Next Y-24.44%
EPS Next 2Y5.3%
EPS Next 3Y14.19%
EPS Next 5Y15.08%
Revenue 1Y (TTM)12.78%
Revenue growth 3Y24.62%
Revenue growth 5Y14.82%
Sales Q2Q%-21.28%
Revenue Next Year-6.72%
Revenue Next 2Y2.78%
Revenue Next 3Y7.18%
Revenue Next 5Y8.29%
EBIT growth 1Y-12.32%
EBIT growth 3Y20.33%
EBIT growth 5Y19.92%
EBIT Next Year-2%
EBIT Next 3Y20.89%
EBIT Next 5Y19.07%
FCF growth 1Y-187.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-102.99%
OCF growth 3YN/A
OCF growth 5YN/A

SUSS MICROTEC SE / SMHN.DE Fundamental Analysis FAQ

What is the fundamental rating for SMHN stock?

ChartMill assigns a fundamental rating of 4 / 10 to SMHN.DE.


What is the valuation status of SUSS MICROTEC SE (SMHN.DE) stock?

ChartMill assigns a valuation rating of 2 / 10 to SUSS MICROTEC SE (SMHN.DE). This can be considered as Overvalued.


What is the profitability of SMHN stock?

SUSS MICROTEC SE (SMHN.DE) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for SMHN stock?

The Price/Earnings (PE) ratio for SUSS MICROTEC SE (SMHN.DE) is 23.13 and the Price/Book (PB) ratio is 3.63.


Can you provide the expected EPS growth for SMHN stock?

The Earnings per Share (EPS) of SUSS MICROTEC SE (SMHN.DE) is expected to decline by -24.44% in the next year.